2025

Imminent Infringement: How far can you go? 

/ By / Patent

Be warned, Long post ahead! The Court of Appeal (COA) of the Unified Patent Court (UPC) in Boehringer Ingelheim v. Zentiva (Boehringer Ingelheim) on 13th August 2025, issued an order addressing the pretty knotty question of when a preliminary injunction should be granted when an applicant (in this case, Boehringer) claims that infringement has not yet taken place but is imminent. This is somewhat similar to a Quia timet action under Indian law, where an interim injunction is sought because […]

Imminent Infringement: How far can you go?  Read More »

SpicyIP Weekly Review (August 11 – August 17)

/ By / Copyright, Others, Patent, Trademark

A patent and litigation update on the anti-diabetic medication Semaglutide, the how’s and why’s of an interview in the context of IP research, and the copyright history of the Indian national anthem. This and a lot more on last week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment below to let us know. Highlights of the Week Gauging the ‘Weight’ of the Matter: Here’s Your Latest Patent and Litigation Update on Semaglutide Semaglutide continues to make

SpicyIP Weekly Review (August 11 – August 17) Read More »

Bench and Bot – The Kerala HC’s AI Guidelines and the Bigger Judicial Puzzle

/ By / Others

On the Kerala High Court publishing its “Policy Regarding Use of Artificial Intelligence Tools in District Judiciary“, Shailraj Jhalnia discusses the judicial use of AI in different jurisdictions and the trend of Courts turning to use AI tools. He also discusses the asymmetry in having the guidelines apply only to district courts, and not appellate courts. Shailraj is a third year law student pursuing B.A. LL.B. from National Law School of India University, Bangalore, with a keen interest in IP Law,

Bench and Bot – The Kerala HC’s AI Guidelines and the Bigger Judicial Puzzle Read More »

https://i.imgflip.com/a35rdu.jpg

Gauging the ‘Weight’ of the Matter: Here’s Your Latest Patent and Litigation Update on Semaglutide

/ By / Patent

Still on the Scales: The Ongoing Patent Battle for Semaglutide Back in May 2025, the order (pdf) by the Delhi High Court (DHC), the Single Bench (SB) comprising Justice Amit Bansal, granted Novo Nordisk an interim injunction, preventing Indian companies Dr. Reddy’s Laboratories (DRL) and OneSource Specialty Pharma from selling or marketing semaglutide (the key ingredient in Ozempic/Wegovy) within India. However, they were allowed to manufacture and export to countries where Novo Nordisk’s patent does not apply. The order arose

Gauging the ‘Weight’ of the Matter: Here’s Your Latest Patent and Litigation Update on Semaglutide Read More »

From the Archives: A Telling Tale of Copyright Over the Indian National Anthem, Jana Gana Mana

/ By / Copyright, Others

Wishing our readers a very Happy Independence Day in advance! May this year bring love, luck, and lights into your life … get you the “freedom” in every beautiful sense of the word! Today, I bring to you a little gem from the archives. Yes … it’s a story of copyright, authorial control, and national unity, all wrapped around the Indian national anthem, Jana Gana Mana. And really … What better day to unspool this spiel than the 79th year

From the Archives: A Telling Tale of Copyright Over the Indian National Anthem, Jana Gana Mana Read More »

Methodological Reflections: The “How” of doing Interviews in IP legal Research

/ By / Others

Exploring the use of interviews as a legal methodology in IP research, particularly in the context of field engagement with traditional artisan communities, Niharika Salar shares a reflective piece based on her fieldwork experience as part of her ongoing PhD project. Niharika is a Doctoral Candidate at Queen’s University Belfast, and her previous posts can be accessed here and here. [Long post ahead] Methodological Reflections: The “How” of doing Interviews in IP legal Research By Niharika Salar In IP legal

Methodological Reflections: The “How” of doing Interviews in IP legal Research Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (August 04 – August 10)

/ By / Copyright, Design, Others, Patent, Trademark

McDonald’s “Mc” prefix at the centre of a trademark battle, a new twist in the Pertuzumab biosimilar case at the Delhi HC in Roche v. Zydus, trademark and colour combination in the news again in Exide Industries v Amara Raja Energy. This and a lot more on last week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment below to let us know. Highlights of the Week The “Mc”Monopoly: Is McDonald’s Building a Trademark Empire on a

SpicyIP Weekly Review (August 04 – August 10) Read More »

Dura-Line v. Jain Irrigation: Where the Design’s Test Holds Water but TSM Leaks

/ By / Design, Patent

Explaining the Delhi High Court judgement in Duraline v Jain Irrigation, Srishti Gaur highlights how it stands out for its findings on design infringement, but falls short on the obviousness analysis of the suit patent. Srishti is a third-year student at National Law University, Delhi. Her previous post can be accessed here. Dura-Line v. Jain Irrigation: Where the Design’s Test Holds Water but TSM Leaks By Srishti Gaur On 19th May, 2025, in Dura-Line India Pvt Ltd v Jain Irrigation

Dura-Line v. Jain Irrigation: Where the Design’s Test Holds Water but TSM Leaks Read More »

Similar Isn’t Identical? How the Roche v. Zydus Judgment Interprets Section 104A

/ By / Patent

The Delhi High Court, in its recent Pertuzumab patent dispute decision, interpreted the application of Section 104A in biologics patent disputes. Breaking down the decision, Subhalaxmi Mukherjee writes on what the provision seeks to prevent and how the Court clarified its scope to curb fishing expeditions in pharma patent disputes. Subhalaxmi is a third-year B.Sc LL.B. (Hons.) student at the West Bengal National University of Juridical Sciences (WBNUJS), Kolkata. She is interested in a wide range of public and commercial

Similar Isn’t Identical? How the Roche v. Zydus Judgment Interprets Section 104A Read More »

Webinar on Breaking Barriers to SMA (Spinal Muscular Atrophy) Treatment (August 8)

/ By / Event

The Working Group on Access to Medicines and Treatment invites you to a webinar on breaking barriers to SMA (Spinal Muscular Atrophy) Treatment. The webinar will be conducted on August 8, 6:30 PM. Please read below for the details. Webinar on Breaking Barriers to SMA (Spinal Muscular Atrophy) Treatment (August 8) Persons with Spinal Muscular Atrophy (SMA) in India face more than a medical diagnosis—they endure systemic delays, financial ruin, and legal battles merely to live. While life-saving treatments like Risdiplam

Webinar on Breaking Barriers to SMA (Spinal Muscular Atrophy) Treatment (August 8) Read More »

Scroll to Top